Clinical quality assurance for endovascular brachytherapy devices

Radiotherapy and Oncology

Volumn 71, Issue 1, 2004, Pages 91-98

  Kirisits, Christian ^a   Stemberger, Andreas ^a   Pokrajac, Boris ^a   Glogar, Dietmar ^a   Pötter, Richard ^a   Georg, Dietmar ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Dosimetry; Endovascular brachytherapy; Quality assurance; Restenosis

Indexed keywords

COBALT 60; IRIDIUM 192; PHOSPHORUS 32; STRONTIUM 90;

ARTICLE; CALIBRATION; CATHETER; CONTRAST MEDIUM EXTRAVASATION; DEVICE; DOSIMETRY; GOOD LABORATORY PRACTICE; MEASUREMENT; PRIORITY JOURNAL; RADIATION DOSE; RADIOISOTOPE THERAPY; REFERENCE VALUE;

BETA RAYS; BRACHYTHERAPY; CATHETERIZATION; EQUIPMENT SAFETY; GAMMA RAYS; HUMANS; QUALITY CONTROL;

EID: 1842579676     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2003.12.007     Document Type: Article

References (23)

1. Bambynek M., Flühs D., Quast U., et al. A high-precision, high-resolution and fast dosimetry system for beta sources applied in cardiovascular brachytherapy. Med Phys. 27:2000;662-667.
2. 90Y beta particles. Med Phys. 228:2001;1010-1015.
3. Cross W.G. Variation of beta dose attenuation in different media. Phys Med Biol. 13:1968;611-618.
4. Duggan D.M., Coffey C.W., Lobdell J.L., Schell M.C. Radiochromic film dosimetry of a high dose rate beta source for intravascular brachytherapy. Med Phys. 26:1999;2461-2464.
5. IAEA TECDOC-1274. Calibration of photon and beta ray sources used in brachytherapy. Guidelines on standardized procedures at Secondary Standards Dosimetry Laboratories (SSDLs) and Hospitals. International Atomic Energy Ageny; 2002.
6. ICRU Report 56: Dosimetry of external beta rays for radiation protection. International Commission on Radiation Units and Measurements, Bethesda, MD; 1997.
7. Kirisits C., Georg D., Wexberg P., et al. Determination and application of the reference isodose length (RIL) for commercial endovascular brachytherapy devices. Radiother Oncol. 64:2002;309-315.
8. Leon M.B., Teirstein P.S., Moses J.W., et al. Localized intracoronary gamma-radiation therapy to inhibit the recurrence of restenosis after stenting. N Engl J Med. 344:2001;250-256.
9. 32P catheter-based vascular brachytherapy source wire. Med Phys. 27:2000;1770-1776.
10. Nath R., Anderson L., Luxton G., et al. Dosimetry of interstitial brachytherapy sources. Recommendations of the AAPM Radiation Therapy Committee Task Group Nr. 43. Med Phys. 22:1995;209-234.
11. Nath R., Amols H., Coffey C., et al. Intravascular brachytherapy physics: Report of the AAPM Radiation Therapy Committee Task Group No. 60. Med Phys. 26:1999;119-152.
12. NCS Recommendations. Elfrink R.J.M., van Kleffens H.J., Kolkman-Deurloo I.K.K., et al. Quality control in brachytherapy: current practice and minimum requirements. Report 13. 2001;The Netherlands Commission on Radiation Dosimetry (NCS), Leiden.
13. Niroomand-Rad A., Blackwell C.R., Coursey B.M., et al. Radiochromic film dosimetry: Recommendations of AAPM Radiation Therapy Committee Task Group 55. Med Phys. 25:1998;2093-2115.
14. Piessens M., Reynaert N. Verification of absolute dose rates for intravascular brachytherapy beta sources. Phys Med Biol. 45:2000;2219-2231.
15. Pötter R., van Limbergen E., Dries W., et al. Recommendations of the EVA GEC ESTRO working group: prescribing, recording and reporting in endovascular brachytherapy. Quality assurance, equipment, personnel and education. Radiother Oncol. 59:2001;339-360.
16. 192Ir HDR brachytherapy for prophylaxis of restenosis after femoro-popliteal angioplasty: the prospective randomized Vienna-2 Trial: radiotherapy parameters and risk factor analysis. Int J Radiat Oncol Biol Phys. 48:2000;923-931.
17. Quast U., Kaulich T.W., Flühs D. Guideline for medical physical aspects of intravascular brachytherapy Part I: guideline. Z Med Phys. 12:2002;47-64.
18. Quast U., Kaulich T.W., Flühs D. Guideline for medical physical aspects of intravascular brachytherapy PartII: samples and examples. Z Med Phys. 12:2002;133-148.
19. 192Ir sources used for endovascular brachytherapy. Phys Med Biol. 46:2001;499-516.
20. Schaart D.R. The scaling method applied to beta line sources with a finite diameter. Med Phys. 29:2002;2682-2686.
21. Soares C.G., Halpern D.G., Wang C.K. Calibration and characterization of beta-particle sources for intravascular brachytherapy. Med Phys. 25:1998;339-346.
22. Verin V., Popowski Y., deBruyne B., et al. Endoluminal beta radiation therapy for the prevention of coronary restenosis after balloon angioplasty. The dose finding study group. N Engl J Med. 344:2001;243-249.
23. Waksman R., White R.L., Chan R.C., et al. Intracoronary gamma-radiation therapy after angioplasty inhibits recurrence in patients with in-stent restenosis. Circulation. 101:2000;2165-2171.